申请人:Takemiya Akihiro
公开号:US20070173537A1
公开(公告)日:2007-07-26
The present invention can provide a cancer treatment drug containing, as an active ingredient, a substance selected from the group consisting of an indazole compound of the following formula (I), a pharmaceutically acceptable salt, a hydrate, a water adduct and a solvate:
本发明可以提供一种癌症治疗药物,其包含以下公式(I)中的吲唑化合物、药用可接受盐、水合物、水加合物和溶剂化物等物质中所选的一种作为活性成分: